Wednesday, March 26, 2014
Tuesday, March 25, 2014
The Washington Post (3/25, Millman) “Wonkblog” reports that a research letter published March 24 in “JAMA Internal Medicine found that use of e-cigarettes was not associated with ‘greater rates of quitting cigarettes or reduced cigarette consumption’ after one year.” The study “authors reached the conclusion based on self-reported data from 949 smokers, which included 88 who used e-cigarettes.”
The Los Angeles Times (3/25, MacVean) “Science Now” blog reports that “researchers from the Center for Tobacco Control Research and Education and the Department of Medicine at” the University of California-San Francisco “noted that e-cigarettes are ‘aggressively promoted as smoking cessation aids.’” But, given the findings of the study, “‘regulations should prohibit advertising, claiming or suggesting that e-cigarettes are effective smoking cessation devices until claims are supported by scientific evidence,’ the researchers...wrote.”
Still, the Boston Globe (3/25, Kotz) points out that the study’s “small sample size makes it difficult to draw firm conclusions, admits study leader Dr. Pamela Ling, an associate professor of medicine at” UCSF.
Newsday (3/25, Ricks) points out that “earlier this month,” researchers “found in a study of thousands of youths that the addictive nicotine in e-cigs may lure teens to more potent sources of the substance.”
According to MedPage Today (3/25, Phend), an accompanying editorial written by JAMA Internal Medicine editor Mitchell Katz, MD, “further advocated FDA regulation” of e-cigarettes “as drug-delivery devices.” MedPage Today added that the FDA “has regulations in the works that are expected to generally bring the same kind of restrictions to e-cigarettes as to other tobacco products.” Some of the data for the study came from National Cancer Institute-funded research.
Also covering the story are Reuters (3/25, Seaman), theMinneapolis Star Tribune (3/25, Stoxen) “Health Check” blog, the CBS News (3/25, Jaslow) website, Time (3/25, Sifferlin), HealthDay (3/25, Reinberg), Medscape (3/25, Cassels), and a Modern Healthcare (3/25, Johnson, Subscription Publication) blog.
Monday, March 17, 2014
The Wall Street Journal (3/17, Beck, Subscription Publication) reports that research suggests that colon cancer incidence among individuals in the US aged 50 and older has declined 30% of the past decade, with the decline being driven by an increase in colonoscopies.
USA Today (3/17, Szabo) reports that additionally, “death rates from colon cancer...have fallen, declining at a rate of about 3% a year over the past decade, the report found.” The largest “declines in colon cancer incidence were in people over age 65, who qualify for Medicare, which makes colon cancer screenings available for free.” The study also indicated that “declines in colon cancer rates became more dramatic in more recent years, falling at an annual rate of 7.2% a year from 2008 to 2010.”
The National Journal (3/17, Subscription Publication) reports that the findings were published in...CA: A Cancer Journal for Clinicians. Investigators “evaluated data from the CDC and the National Cancer Institute in preparing the report.” The Journal points out that “the data comes as the Health and Human Services Department and National Colorectal Cancer Roundtable – an organization founded by the Centers for Disease Control and Prevention and the American Cancer Society – make a new nationwide push to increase screening rates to 80 percent by 2018.”
Modern Healthcare (3/17, Rice, Subscription Publication) reports, however, that “screening rates remain low among the poor and uninsured, the report said, and there were substantial racial and ethnic differences in both incidence and death rates.” The CNN (3/17) “The Chart” blog and MedPage Today (3/17, Bankhead) also cover the story.